弊社が販売する試薬は全て研究用です。為替変動等の影響により、ページ内に記載されている料金等の金額は全て参考につき、詳細はお気軽にお問い合わせください。
・各種受託合成トップページへ戻る
・関連製品 ・ サービスへ進む
・お問い合わせ ・ ご注文へ進む
This service / product is supplied by
,
, etc.
カスタムペプチド合成受託サービスの末端修飾や蛍光色素標識などの修飾と料金の一覧ですが、こちらに記載がない場合もお気軽にお問い合わせください。
ペプチド合成受託サービスのさまざまな修飾
価格やキャンペーン、見積もりのご依頼はこちらのカスタムペプチド合成受託サービスのトップページからお気軽にお問い合わせください。
N末端修飾
20mg以上も可能ですのでお問い合わせ下さい。記載の金額は参考料金です。
| Item A | N末端修飾 | 1-9 mg | 10-19 mg |
|---|
| A0 | {H-},Free amino group | 0 | 0 |
| A1 | {Ac},Acetylation | 0 | 0 |
| A2-BrC2 | {Br-Ac},Bromoacetyl | 8,000 | 10,000 |
| A2-BrC3 | {Bromopropionyl} | 8,000 | 10,000 |
| A2-ClC2 | {Cl-Ac},Chloroacetyl | 8,000 | 10,000 |
| A3 | {Fmoc},9-Fluorenylmethyloxycarbonyl | 0 | 0 |
| A4 | {Z},{CBZ},Benzyloxycarbonyl | 0 | 0 |
| A5 | {Bz},benzoyl | 0 | 0 |
| A6 | {Boc},tertbutoxycarbonyl | 18,000 | 19,000 |
| A7 | {Suc},succinyl | 2,000 | 2,000 |
| A8 | {Allyl},allyl | 18,000 | 19,000 |
| A9 | {Acryl},acryl | 18,000 | 19,000 |
| A10 | {Alloc},allyloxycarbonyl | 18,000 | 19,000 |
| A11 | {For}, Formylation | 5,000 | 6,000 |
| A12 | {HPP},4-Hydroxyphenylpropionic acid | 5,000 | 6,000 |
| A13 | {pGlu},{Pyr},Pyroglutamyl | 3,000 | 4,000 |
| A14 | {LA}, Lipoic acid | 5,000 | 6,000 |
| A15-C3 | {Mpa},3-Mercaptopropyl | 5,000 | 6,000 |
| A15-C6 | {6-mercaptohexanoic acid} | 18,000 | 19,000 |
| A16 | {Mal}, Maleimide, Maleoyl-b-Ala | 64,000 | 70,000 |
| A17 | {MTX}, Methotrexate | 18,000 | 19,000 |
| A18 | {PEG1900}, PEG1900-NH- | 18,000 | 19,000 |
| A19-2K-NH2 | {NH2-PEG2000}, NH2-PEG2000-NH- | 18,000 | 19,000 |
| A19-2K-Ome | {mPEG2000}, MeO-PEG2000-NH- | 18,000 | 19,000 |
| A19-3K-Ome | {mPEG3000}, MeO-PEG3000-NH- | 18,000 | 19,000 |
| A19-5K-Ome | {mPEG5000}, MeO-PEG5000-NH- | 18,000 | 19,000 |
| A20 | {SATA}, S-acetylthioacetate | 18,000 | 19,000 |
| A21 | {SATP}, S-acetylthiopropionate | 18,000 | 19,000 |
| A22 | {Cholesteryl-}, Cholesteryl chloroformate | 18,000 | 19,000 |
| A23 | {Glucose-} | 34,000 | 35,000 |
| A24 | Pyridin-1-yl-Acetyl- | 39,000 | 44,000 |
| A25 | 4-Dimethylamino-Pyridin-1-yl- | 39,000 | 44,000 |
| A26 | Adamantanecarbonyl- | 39,000 | 44,000 |
N末端Fatylation
| Item B | N末端Fatylation | 1-9 mg | 10-19 mg |
|---|
| B1 | {But}, Butyric acid C4 | 8,000 | 10,000 |
| B2 | {Hex}, Hexanoic acid C6 | 8,000 | 10,000 |
| B3 | {Oct}, Octanoic acid C8 | 8,000 | 10,000 |
| B3F | {F-Oct}, Perfluoro Octanoic acid F15C8 | 26,000 | 28,000 |
| B4 | {Dec}, Decanoic acid C10 | 8,000 | 10,000 |
| B4F | {F-Dec}, Perfluoro Decanoic acid F19C10 | 26,000 | 28,000 |
| B5 | {Lau}, Lauric acid C12 | 8,000 | 10,000 |
| B5F | {F-Lau}, Perfluoro Lauric acid F23C12 | 26,000 | 28,000 |
| B6 | {Myr}, Myristic acid C14 | 8,000 | 10,000 |
| B6F | {F-Myr}, Perfluoro Myristic acid F27C14 | 26,000 | 28,000 |
| B7 | {Pal}, Palmitic acid C16 | 8,000 | 10,000 |
| B8 | {Ste}, Stearic acid C18 | 8,000 | 10,000 |
| B10 | {Pam3C}, Tripalmitoyl cysteine, {Pal-Cys(Pal)2-} | 52,000 | 55,000 |
C末端修飾
| Item C | C末端修飾 | 1-9 mg | 10-19 mg |
|---|
| C0 | {-OH}, free acid group | 0 | 0 |
| C1 | {NH2}, Amidation | 0 | 0 |
| C2 | {-CHO}, peptide aldehydes | 74,000 | 81,000 |
| C3 | {-ol}, alcohol peptide | 34,000 | 35,000 |
| C4 | {CMK}, chloromethylketone | 74,000 | 81,000 |
| C5 | {FMK}, Fluoromethylketone | 74,000 | 81,000 |
| C6 | {Cya}, Cysteamide | 34,000 | 35,000 |
| C7 | {pNA},p-nitroaniline | 26,000 | 28,000 |
| C8 | {-pNP}, para-nitrophenol | 34,000 | 35,000 |
| C9 | {AMC},7-Amino-4-methylcoumarin | 34,000 | 35,000 |
| C10 | {AFC} | 44,000 | 46,000 |
| C11 | -OMe (C-terminal) | 16,000 | 19,000 |
| C12 | -OEt (C-terminal) | 16,000 | 19,000 |
| C13 | -OBzl (C-terminal) | 16,000 | 19,000 |
| C14 | -OtBu (C-terminal) | 34,000 | 35,000 |
| C15 | {-OSu}, hydroxysucinimide ester | 74,000 | 81,000 |
| C16 | -NHMe (C-terminal) | 26,000 | 28,000 |
| C17 | -NHEt (C-terminal) | 26,000 | 28,000 |
| C18 | -NHisopen (C-terminal) | 39,000 | 44,000 |
| C19 | -NH(CH2)6 (C-terminal) | 39,000 | 44,000 |
| C20 | -NHPh (C-terminal) | 26,000 | 28,000 |
| C21 | {NHEt(O)EtNH-Fmoc}, 2,2′-Oxydi Ethanamine-Fmoc | 34,000 | 35,000 |
| C22 | {NHEt(EtNH-Myr)2} | 39,000 | 44,000 |
| C23 | -NH(OMe)Me (C-terminal) | 39,000 | 44,000 |
| C24 | -TBzl (C-terminal) | 34,000 | 35,000 |
| C25 | -NHNH2 (C-terminal) | 26,000 | 28,000 |
| C26 | -ED (C-terminal), -NH-CH2CH2-NH2 | 26,000 | 28,000 |
| C27 | -BD (C-terminal), -NH-CH2CH2CH2CH2-NH2 | 26,000 | 28,000 |
D-form normal amino acid
| Item D | D form normal amino acid | 1-9 mg | 10-19 mg |
|---|
| D1 | {D-Ala} | 3,000 | 4,000 |
| D2 | {D-Arg} | 8,000 | 10,000 |
| D3 | {D-Asp} | 5,000 | 6,000 |
| D4 | {D-Asn} | 5,000 | 6,000 |
| D5 | {D-Cys} | 5,000 | 6,000 |
| D6 | {D-Glu} | 5,000 | 6,000 |
| D7 | {D-Gln} | 6,000 | 8,000 |
| D8 | {D-His} | 5,000 | 6,000 |
| D9 | {D-Allo-Ile} | 6,000 | 8,000 |
| D10 | {D-Leu} | 3,000 | 4,000 |
| D11 | {D-Lys} | 5,000 | 6,000 |
| D12 | {D-Met} | 3,000 | 4,000 |
| D13 | {D-Pro} | 3,000 | 4,000 |
| D14 | {D-Phe} | 3,000 | 4,000 |
| D15 | {D-Ser} | 5,000 | 6,000 |
| D16 | {D-Tyr} | 5,000 | 6,000 |
| D17 | {D-Thr} | 5,000 | 6,000 |
| D18 | {D-Trp} | 8,000 | 10,000 |
| D19 | {D-Val} | 3,000 | 4,000 |
Unusual amino acid
| Item E | Unusual amino acid | 1-9 mg | 10-19 mg |
|---|
| E1 | {Beta-Asp} | 5,000 | 6,000 |
| E2 | {D-Beta-Asp} | 6,000 | 8,000 |
| E3 | {Gamma-Glu} | 5,000 | 6,000 |
| E4 | {D-Gamma-Glu} | 6,000 | 8,000 |
| E5 | {Cys(Cam)} | 5,000 | 6,000 |
| E6 | {Cys(Acm)} | 5,000 | 6,000 |
| E7 | {Cys(tBu)} | 5,000 | 6,000 |
| E8 | {Met(O)} | 6,000 | 8,000 |
| E9 | {D-Met(O)} | 8,000 | 10,000 |
| E10 | {Met(O)2} | 6,000 | 8,000 |
| E11 | {D-Met(O)2} | 8,000 | 10,000 |
| E12 | {Lys(Ac)} | 5,000 | 6,000 |
| E13 | {Ac-Lys} | 6,000 | 8,000 |
| E14 | {Lys(Dde)} | 23,000 | 27,000 |
| E15 | {Lys(Alloc)} | 15,000 | 17,000 |
| E16 | {Ser(octanoic acid)} | 36,000 | 39,000 |
| E17 | {D-Ser(octanoic acid)} | 36,000 | 39,000 |
| E18 | {Aib} | 5,000 | 6,000 |
| E19 | {Abu} | 5,000 | 6,000 |
| E20 | {D-Abu} | 5,000 | 6,000 |
| E21 | {Hyp} | 3,000 | 4,000 |
| E22 | {Phg} | 3,000 | 4,000 |
| E23 | {D-Phg} | 3,000 | 4,000 |
| E24 | {Nva} | 5,000 | 6,000 |
| E25 | {D-Nva} | 5,000 | 6,000 |
| E26 | {Nle} | 5,000 | 6,000 |
| E27 | {D-Nle} | 5,000 | 6,000 |
| E28 | {Cit} | 5,000 | 6,000 |
| E29 | {D-Cit} | 6,000 | 8,000 |
| E30 | {Orn} | 5,000 | 6,000 |
| E31 | {D-Orn} | 6,000 | 8,000 |
| E32 | {Pen} | 10,000 | 12,000 |
| E33 | {D-Pen} | 5,000 | 6,000 |
| E34 | {Cpg}, cyclopentylglycine | 6,000 | 8,000 |
| E35 | {Cha} | 5,000 | 6,000 |
| E36 | {D-Cha} | 5,000 | 6,000 |
| E37 | {Chg} | 5,000 | 6,000 |
| E38 | {D-Chg} | 5,000 | 6,000 |
| E39 | {Dab} | 6,000 | 8,000 |
| E40 | {Dap} | 6,000 | 8,000 |
| E41 | {Pra} | 6,000 | 8,000 |
| E42 | {D-Pra} | 6,000 | 8,000 |
| E43 | {Gly(allyl)} | 6,000 | 8,000 |
| E44 | {D-Gly(allyl)} | 6,000 | 8,000 |
| E45 | {D-1-Nal} | 5,000 | 6,000 |
| E46 | {L-1-Nal} | 5,000 | 6,000 |
| E47 | {D-2-Nal} | 5,000 | 6,000 |
| E48 | {L-2-Nal} | 5,000 | 6,000 |
| E49 | {D-2-Pal} | 5,000 | 6,000 |
| E50 | {L-2-Pal} | 5,000 | 6,000 |
| E51 | {D-3-Pal} | 5,000 | 6,000 |
| E52 | {L-3-Pal} | 5,000 | 6,000 |
| E53 | {D-4-Pal} | 5,000 | 6,000 |
| E54 | {L-4-Pal} | 5,000 | 6,000 |
| E55 | {Cys(pMeBzl)} | 5,000 | 6,000 |
| E56 | {Cys(pMeOBzl)} | 5,000 | 6,000 |
| E57 | {Oic} | 6,000 | 8,000 |
| E58 | {Tic} | 6,000 | 8,000 |
| E59 | {Cys(Bzl)} | 5,000 | 6,000 |
| E60 | {Epsilon-Lys} | 5,000 | 6,000 |
| E61 | {D-Epsilon-Lys} | 6,000 | 8,000 |
| E62 | {5-ASA} | 18,000 | 19,000 |
| E63 | {Bpa} | 18,000 | 19,000 |
| E64 | {Pip} | 6,000 | 8,000 |
| E65 | {Nip} | 8,000 | 10,000 |
| E66 | {2-Aze} | 8,000 | 10,000 |
| E67 | {3-Aze} | 10,000 | 12,000 |
| E68 | [Psi(CH2NH)] | 126,000 | 136,000 |
| E69 | [CS-NH] | 126,000 | 136,000 |
| E70 | {Lys(propionyl)} | 15,000 | 16,000 |
| E71 | {Lys(Butanoyl)} | 15,000 | 16,000 |
| E72 | {Lys(propargyl)} | 15,000 | 16,000 |
| E73 | {X}, 20 Kinds mixture amino acids | 5,000 | 6,000 |
| E74 | {isoGln} | 10,000 | 12,000 |
| E75 | {D-isoGln} | 15,000 | 16,000 |
| E76 | Cys(Mal-PEG2000) | 63,000 | 68,000 |
| E77 | {Ser(O-b-D-Glc)} | 126,000 | 136,000 |
| E78 | {Thr(O-b-D-Glc)} | 126,000 | 136,000 |
| E79 | {Tyr(O-b-D-Glc)} | 126,000 | 136,000 |
Fluorescence/Dye Labeling
| Item F | Fluorescence/Dye Labeling | 1-9 mg | 10-19 mg |
|---|
| F1 | Biotin (N-Terminal) | 5,000 | 6,000 |
| F1L | Biotin-LC (N-Terminal) | 5,000 | 6,000 |
| F1K | Lys(Biotin) (middle) | 31,000 | 33,000 |
| F1KC | Lys(Biotin) (C temrinus) | 31,000 | 33,000 |
| F1KN | Lys(Biotin) (N terminus) | 15,000 | 16,000 |
| F1ED | EDBiotin (C terminus) | 39,000 | 43,000 |
| F2L | FITC-LC (N-Terminal) | 18,000 | 19,000 |
| F2K | Lys(FITC) (middle) | 39,000 | 43,000 |
| F2KC | Lys(FITC) (C temrinus) | 39,000 | 43,000 |
| F2KN | Lys(FITC) (N terminus) | 19,000 | 21,000 |
| F2ED | EDFITC (C temrinus) | 46,000 | 51,000 |
| F3 | 5-FAM (N-Terminal) | 18,000 | 19,000 |
| F3L | 5-FAM-LC (N-Terminal) | 18,000 | 19,000 |
| F3K | Lys(5-FAM) (middle) | 39,000 | 43,000 |
| F3KC | Lys(5-FAM) (C temrinus) | 39,000 | 43,000 |
| F3KN | Lys(5-FAM) (N-Terminus) | 19,000 | 21,000 |
| F3ED | ED5-FAM (C temrinus) | 46,000 | 51,000 |
| F4 | Dansyl (N-Terminal) | 18,000 | 19,000 |
| F4L | Dansyl-LC (N-Terminal) | 18,000 | 19,000 |
| F4K | Lys(Dansyl) (middle) | 39,000 | 43,000 |
| F4KC | Lys(Dansyl) (C temrinus) | 39,000 | 43,000 |
| F4KN | Lys(Dansyl) (N-Terminus) | 19,000 | 21,000 |
| F4ED | EDDansyl (C temrinus) | 46,000 | 51,000 |
| F5 | TAMRA (N-Terminal) | 37,000 | 39,000 |
| F5L | TAMRA-LC (N-Terminal) | 37,000 | 39,000 |
| F5K | Lys(TAMRA) (middle) | 63,000 | 68,000 |
| F5KC | Lys(TAMRA) (C temrinus) | 63,000 | 68,000 |
| F5KN | Lys(TAMRA) (N-terminus) | 32,000 | 34,000 |
| F5ED | EDTAMRA (C temrinus) | 76,000 | 81,000 |
| F6 | Lys(Dnp) (middle) | 15,000 | 17,000 |
| F6-D | D-Lys(Dnp) (middle) | 31,000 | 35,000 |
| F6-Dab | Dab(Dnp) (middle) | 31,000 | 35,000 |
| F6-Dap | Dap(Dnp) (middle) | 31,000 | 35,000 |
| F6-ED | EDDnp (C terminus) | 46,000 | 51,000 |
| F7 | MCA (N-Terminal) | 18,000 | 19,000 |
| F7K | Lys(MCA) (middle) | 63,000 | 68,000 |
| F7KC | Lys(MCA) (C temrinus) | 63,000 | 68,000 |
| F7KN | Lys(MCA) (N-terminus) | 32,000 | 34,000 |
| F8 | 3-Indolylacetic acid (N-Terminal) | 5,000 | 6,000 |
| F9 | Cys(Npys) (N-terminus) | 15,000 | 17,000 |
| F10 | PyBA- (N-Terminal), 1-pyrenebutyric acid | 18,000 | 19,000 |
| F11 | Fa- (N-Terminal), 3-[2-2furyl]acrylic acid | 18,000 | 19,000 |
| F12 | Rhodamine B- (N-Terminal) | 18,000 | 19,000 |
| F13 | D-Luciferin (N-terminus) | 68,000 | 77,000 |
| F14 | Cy3- (N-Terminal) | 68,000 | 77,000 |
Phe/Tyr Analogs amino acid
| Item G | Phe/Tyr Analogs amino acid | 1-9 mg | 10-19 mg |
|---|
| G1 | {D-2-Cl-Phe} | 6,000 | 8,000 |
| G2 | {L-2-Cl-Phe} | 6,000 | 8,000 |
| G3 | {D-3-Cl-Phe} | 6,000 | 8,000 |
| G4 | {L-3-Cl-Phe} | 6,000 | 8,000 |
| G5 | {D-4-Cl-Phe} | 5,000 | 6,000 |
| G6 | {L-4-Cl-Phe} | 5,000 | 6,000 |
| G7 | {D-3,4-DiCl-Phe} | 8,000 | 10,000 |
| G8 | {L-3,4-DiCl-Phe} | 8,000 | 10,000 |
| G9 | {D-4-Br-Phe} | 5,000 | 6,000 |
| G10 | {L-4-Br-Phe} | 5,000 | 6,000 |
| G11 | {D-3-F-Phe} | 6,000 | 8,000 |
| G12 | {L-3-F-Phe} | 6,000 | 8,000 |
| G13 | {D-4-F-Phe} | 5,000 | 6,000 |
| G14 | {L-4-F-Phe} | 5,000 | 6,000 |
| G15 | {D-4-NO2-Phe} | 5,000 | 6,000 |
| G16 | {L-4-NO2-Phe} | 5,000 | 6,000 |
| G17 | {D-4-I-Phe} | 5,000 | 6,000 |
| G18 | {L-4-I-Phe} | 5,000 | 6,000 |
| G19 | {D-3-CN-Phe} | 6,000 | 8,000 |
| G20 | {L-3-CN-Phe} | 6,000 | 8,000 |
| G21 | {D-4-CN-Phe} | 5,000 | 6,000 |
| G22 | {L-4-CN-Phe} | 5,000 | 6,000 |
| G23 | {D-2-Me-Phe} | 6,000 | 8,000 |
| G24 | {L-2-Me-Phe} | 6,000 | 8,000 |
| G25 | {D-4-Me-Phe} | 5,000 | 6,000 |
| G26 | {L-4-Me-Phe} | 5,000 | 6,000 |
| G27 | {D-4-NH2-Phe} | 8,000 | 10,000 |
| G28 | {L-4-NH2-Phe} | 8,000 | 10,000 |
| G29 | {D-3-Cl-Tyr} | 8,000 | 10,000 |
| G30 | {L-3-Cl-Tyr} | 5,000 | 6,000 |
| G31 | {D-3,5-DiCl-Tyr} | 8,000 | 10,000 |
| G32 | {L-3,5-DiCl-Tyr} | 8,000 | 10,000 |
| G33 | {D-3,5-DiBr-Tyr} | 8,000 | 10,000 |
| G34 | {L-3,5-DiBr-Tyr} | 8,000 | 10,000 |
| G35 | {D-3-I-Tyr} | 8,000 | 10,000 |
| G36 | {L-3-I-Tyr} | 8,000 | 10,000 |
| G37 | {D-3,5-DiI-Tyr} | 8,000 | 10,000 |
| G38 | {L-3,5-DiI-Tyr} | 8,000 | 10,000 |
| G39 | {D-3-NO2-Tyr} | 8,000 | 10,000 |
| G40 | {L-3-NO2-Tyr} | 5,000 | 6,000 |
| G41 | {D-3,5-DiNO2-Tyr} | 8,000 | 10,000 |
| G42 | {L-3,5-DiNO2-Tyr} | 8,000 | 10,000 |
Homo amino acid
| Item H | Homo amino acid | 1-9 mg | 10-19 mg |
|---|
| H1 | {Har}, HomoArg | 6,000 | 8,000 |
| H2 | {Hcy}, HomoCys | 5,000 | 6,000 |
| H3 | {HPh}, HomoPhe | 6,000 | 8,000 |
| H4 | {D-HPh}, D-HomoPhe | 6,000 | 8,000 |
| H5 | {Hse}, HomoSer | 5,000 | 6,000 |
| H6 | {D-Hse}, D-HomoSer | 6,000 | 8,000 |
| H7 | {HomoCit}, HomoCit | 6,000 | 8,000 |
| H8 | {D-HomoCit}, D-HomoCit | 6,000 | 8,000 |
| H9 | {HomoLeu}, HomoLeu | 6,000 | 8,000 |
| H10 | {HomoPro}, HomoPro | 6,000 | 8,000 |
| H11 | {D-HomoPro}, D-HomoPro | 6,000 | 8,000 |
| H12 | {beta-HomoIle}, beta-HomoIle | 10,000 | 12,000 |
| H13 | {beta-HomoLeu}, beta-HomoLeu | 10,000 | 12,000 |
| H14 | {beta-HomoMet}, beta-HomoMet | 10,000 | 12,000 |
| H15 | {beta-HomoPro}, beta-HomoPro | 10,000 | 12,000 |
| H16 | {beta-HomoVal}, beta-HomoVal | 10,000 | 12,000 |
| H17 | {beta-HomoAsp}, beta-HomoAsp | 19,000 | 23,000 |
| H18 | {beta-HomoAsn}, beta-HomoAsn | 19,000 | 23,000 |
| H19 | {beta-HomoGlu}, beta-HomoGlu | 19,000 | 23,000 |
| H20 | {beta-HomoGln}, beta-HomoGln | 19,000 | 23,000 |
| H21 | {beta-HomoSer}, beta-HomoSer | 19,000 | 23,000 |
| H22 | {beta-HomoThr}, beta-HomoThr | 19,000 | 23,000 |
| H23 | {beta-HomoTrp}, beta-HomoTrp | 19,000 | 23,000 |
| H24 | {beta-HomoTyr}, beta-HomoTyr | 19,000 | 23,000 |
Isotope label
| Item I | Isotope label | 1-9 mg | 10-19 mg |
|---|
| I1 | N15 Ala | 16,000 | 23,000 |
| I2 | N15 Gly | 16,000 | 23,000 |
| I3 | N15 Val | 16,000 | 23,000 |
| I4 | N15 Pro | 16,000 | 23,000 |
| I5 | N15 Leu | 19,000 | 26,000 |
| I6 | N15 Ile | 19,000 | 26,000 |
| I7 | N15 Phe | 26,000 | 35,000 |
| I8 | N15 Asp | 29,000 | 39,000 |
| I9 | N15 Thr | 29,000 | 39,000 |
| I10 | N15 Glu | 35,000 | 48,000 |
| I11 | N15 Lys | 35,000 | 48,000 |
| I12 | N15 Tyr | 35,000 | 48,000 |
| I13 | N15 Arg | 64,000 | 90,000 |
| I14 | N15 Gln | 64,000 | 90,000 |
Quenched fluorescent peptide
| Item J | Quenched fluorescent peptide | 1-9 mg | 10-19 mg |
|---|
| J1 | Abz/ Tyr (3-NO2) | 15,000 | 17,000 |
| J2 | Abz | 5,000 | 6,000 |
| J3 | Tyr (3-NO2) | 5,000 | 6,000 |
| J4 | Glu(EDANS)-NH2 | 30,000 | 31,000 |
| J5 | DABCYL | 27,000 | 29,000 |
| J6 | DABCYL/Glu(EDANS)-NH2 | 54,000 | 58,000 |
MAPS and Carrier Complex
| Item K | MAPS and Carrier Complex | 1-9 mg | 10-19 mg |
|---|
| K1 | Symmetric 2 Branches (Pure) | 26,000 | 29,000 |
| K1-Orn | Orn Symmetric 2 Branches (Pure) | 31,000 | 35,000 |
| K2 | Symmetric 4 Branches (Crude) | 26,000 | 29,000 |
| K2-Orn | Orn Symmetric 4 Branches (Crude) | 31,000 | 35,000 |
| K3 | Symmetric 8 Branches (Crude) | 26,000 | 29,000 |
| K3-Orn | Orn Symmetric 8 Branches (Crude) | 31,000 | 35,000 |
| K4 | Glu 2 Branches (N temrinus) | 39,000 | 44,000 |
| K5 | Glycerol 3 branches (C terminus) | 39,000 | 44,000 |
| K6 | n-mer Branch peptide on Lys side chain | 52,000 | 55,000 |
| K7 | n-mer Branch peptide on Thr side chain | 62,000 | 66,000 |
| K8 | n-mer Branch peptide on Ser side chain | 62,000 | 66,000 |
| K9-Asp | Lys(Asp) | 39,000 | 43,000 |
| K9-Mpa | Lys(Mpa) | 39,000 | 43,000 |
| K9-Pra | Lys(Pra) | 39,000 | 43,000 |
| K10 | Lys(Maleimide), (middle, C-terminus) | 58,000 | 64,000 |
| K10N | {Lys(Maleimide)}, (N-Terminus) | 29,000 | 32,000 |
| K11-Pal | Lys(Pal) (middle, C-terminus) | 39,000 | 43,000 |
| K11N-Pal | Lys(Pal) (N-Terminus) | 19,000 | 21,000 |
| K11-Ma | Lys(Ma) (middle, C-terminus) | 39,000 | 43,000 |
| K11N-Ma | Lys(Ma) (N-Terminus) | 19,000 | 21,000 |
| K12 | Lys(Alkine) (middle, C-terminus) | 39,000 | 43,000 |
| K12N | Lys(Alkine) (N-Terminus) | 19,000 | 21,000 |
| K13 | Lys(Suc) (middle, C-terminus) | 39,000 | 43,000 |
| K13N | Lys(Suc) (N-Terminus) | 19,000 | 21,000 |
| K14 | Lys(methylmalony) (middle, C-terminus) | 39,000 | 43,000 |
| K14N | Lys(methylmalony) (N-Terminus) | 19,000 | 21,000 |
| K15 | Lys(MTX) (middle, C-terminus) | 39,000 | 43,000 |
| K15N | Lys(MTX) (N-terminus) | 19,000 | 21,000 |
| K16 | Lys(LA) (middle, C-terminus) | 39,000 | 43,000 |
| K16N | Lys(LA) (N-Terminus) | 19,000 | 21,000 |
| K17 | Lys(Crotonyl) (middle, C-terminus) | 39,000 | 43,000 |
| K17N | Lys(Crotonyl) (N-Terminus) | 19,000 | 21,000 |
| K18 | Lys(Cholesteryl) (middle, C-terminus) | 39,000 | 43,000 |
| K18N | Lys(Cholesteryl) (N-Terminus) | 19,000 | 21,000 |
| K19 | Lys(HYNIC) (middle, C-terminus) | 39,000 | 43,000 |
| K19N | Lys(HYNIC) (N-Terminus) | 19,000 | 21,000 |
| K20 | Lys(Gama-Glu-Pal) (middle, C-terminus) | 72,000 | 77,000 |
| K20N | Lys(Gama-Glu-Pal) (N-terminus) | 19,000 | 25,000 |
| K21 | BSA-Peptide N terminus | 32,000 | 32,000 |
| K21C | BSA-Peptide C terminus | 32,000 | 32,000 |
| K21Cys | BSA-Peptide Cys | 35,000 | 39,000 |
| K22 | KLH-Peptide N terminus | 32,000 | 35,000 |
| K22C | KLH-Peptide C terminus | 32,000 | 35,000 |
| K22Cys | KLH-Peptide Cys | 32,000 | 35,000 |
| K23 | OVA-Peptide N terminus | 32,000 | 35,000 |
| K23C | OVA-Peptide C terminus | 32,000 | 35,000 |
| K23Cys | OVA-Peptide Cys | 32,000 | 35,000 |
Atom Linker
| Item L | Atom Linker | 1-9 mg | 10-19 mg |
|---|
| L1 | {Gly}, 2 atoms | 0 | 0 |
| L2 | {Beta-Ala}, 3 atoms | 0 | 0 |
| L3 | {GABA}, 4 atoms | 0 | 0 |
| L4 | {Ava}, 5 atoms | 6,000 | 7,000 |
| L5 | {Ahx}, 6 atoms | 0 | 0 |
| L6 | {Mini-PEG}, AEEA 9 atoms | 6,000 | 7,000 |
| L7 | {Mini-PEG2}, AEEEP 13 atoms | 9,000 | 11,000 |
| L8 | {Mini-PEG3},AEEEEP 16 atoms | 12,000 | 14,000 |
| L9 | {AEA},aminoethoxyacetic acid | 29,000 | 34,000 |
| L10 | {PEG6} | 29,000 | 34,000 |
| L11 | {PEG11} | 29,000 | 34,000 |
Methyl amino acids
| Item M | Methyl amino acids | 1-9 mg | 10-19 mg |
|---|
| M1 | {Arg(Me)} | 46,000 | 52,000 |
| M2 | {ADMA},{Arg(Me)2} asymmetrical | 46,000 | 52,000 |
| M3 | {SDMA},{Arg(Me)2} symmetrical | 62,000 | 70,000 |
| M4 | {Tyr(Me)} | 6,000 | 8,000 |
| M5 | {Thr(Me)} | 6,000 | 8,000 |
| M6 | {Ser(Me)} | 6,000 | 8,000 |
| M7 | {Cys(Me)}, SMC | 5,000 | 6,000 |
| M8 | {Lys(Me)} | 31,000 | 35,000 |
| M9 | {Lys(Me2)} | 15,000 | 17,000 |
| M10 | {Lys(Me3)} | 31,000 | 35,000 |
| M11 | {L-2-Me-Trp} | 37,000 | 43,000 |
| M12 | {D-2-Me-Trp} | 37,000 | 43,000 |
| M13 | {Tyr(Et)} | 15,000 | 17,000 |
| M14 | {D-Tyr(Et)} | 15,000 | 17,000 |
N-Methyl amino acid
| Item N | N-Methyl amino acid | 1-9 mg | 10-19 mg |
|---|
| N1 | {N-Me-Ala} | 25,000 | 27,000 |
| N2 | {N-Me-Phe} | 25,000 | 27,000 |
| N3 | {N-Me-Leu} | 25,000 | 27,000 |
| N4 | {N-Me-Ile} | 25,000 | 27,000 |
| N5 | {N-Me-Val} | 25,000 | 27,000 |
| N6 | {N-Me-Met} | 25,000 | 27,000 |
| N7 | {N-Me-Nle} | 25,000 | 27,000 |
| N8 | {N-Me-Nva} | 25,000 | 27,000 |
| N9 | {N-Me-Gly}, Sar | 3,000 | 4,000 |
| N10 | {N-Me-Ser} | 50,000 | 54,000 |
| N11 | {N-Me-Tyr} | 50,000 | 54,000 |
| N12 | {N-Me-Thr} | 50,000 | 54,000 |
| N13 | {N-Me-Asp} | 50,000 | 54,000 |
| N14 | {N-Me-Glu} | 50,000 | 54,000 |
Cyclic peptide
| Item O | Cyclic peptide | 1-9 mg | 10-19 mg |
|---|
| O1 | Mono Disulfide bridge | 26,000 | 29,000 |
| O2 | Double Disulfide bridge | 86,000 | 94,000 |
| O3 | Triple Disulfide bridge | 344,000 | 384,000 |
| O4 | Random Triple Disulfide bridge | 52,000 | 58,000 |
| O5 | Same Seq. Inter-Disulfide bridge | 26,000 | 29,000 |
| O6 | Different Inter-Disulfide bridge | 52,000 | 58,000 |
| O7 | Amide cyclic (end) | 90,000 | 97,000 |
| O8 | Amide cyclic (Side chain) | 103,000 | 113,000 |
| O9 | Thioester cyclic | 86,000 | 94,000 |
| O10 | Lactone cyclic | 86,000 | 94,000 |
Phosphorylation
| Item P | Phosphorylation | 1-9 mg | 10-19 mg |
|---|
| P1 | {pSer} | 15,000 | 17,000 |
| P2 | {pTyr} | 15,000 | 17,000 |
| P3 | {pThr} | 15,000 | 17,000 |
| P4 | {D-pSer} | 46,000 | 52,000 |
| P5 | {D-pTyr} | 46,000 | 52,000 |
| P6 | {D-pThr} | 46,000 | 52,000 |
| P7 | Di-sites in sequence | 46,000 | 52,000 |
| P8 | Tri-sites in sequence | 93,000 | 105,000 |
| P9 | 4-sites in sequence | 139,000 | 157,000 |
| P10 | 5-sites in sequence | 186,000 | 209,000 |
その他・オプション等
| Item Q | Others | 1-9 mg | 10-19 mg |
|---|
| Item QA | GMP Clean Room Process | 107,000 | |
| Item QB | Aliquoting / vial | 200 | |
| Item QC | Amino Acid Analysis (AAA) | 15,000 | |
| Item QD | N elemental Analysis | 10,000 | |
| Item QE | Solubility test | – | |
| Item QF | Microbial analysis | – | |
| Item QG | Water content (Karl Fischer) | 4,000 | |
| Item QH | Acetate Content (HIPC) | 15,000 | |
| Item QI | Maldi-Tof MS | 6,000 | |
| Item QJ | Endotoxin analysis | 12,000 | |
| Item QK | Switch salt | Inquire | |
| Q1 | Arg(pbf) | Inquire | |
| Q2 | Asp(OtBu) | Inquire | |
| Q3 | Asn(Trt) | Inquire | |
| Q4 | Cys(Trt) | Inquire | |
| Q5 | Glu(OtBu) | Inquire | |
| Q6 | Gln(Trt) | Inquire | |
| Q7 | His(Trt) | Inquire | |
| Q8 | Lys(Boc) | Inquire | |
| Q9 | Ser(tBu) | Inquire | |
| Q10 | Tyr(tBu) | Inquire | |
| Q11 | Thr(tBu) | Inquire | |
| Q12 | Trp(Boc) | Inquire | |
| Q13 | Wang Resin | Inquire | |
| Q14 | 2-CTC Resin | Inquire | |
| Q15 | Rink Amide AM resin | Inquire | |
| Q16 | Rink Amide MBHA resin | Inquire | |
上記リンク先ページのお問い合わせフォームをご利用ください。